Chat with us
Research Assistance
Online
  • Please enter your first name.

Japan Exosomes Market Size & Outlook, 2026-2033

The exosomes market in Japan is expected to reach a projected revenue of US$ 34.1 million by 2030. A compound annual growth rate of 28.9% is expected of Japan exosomes market from 2025 to 2030.

  • Biotechnology
    • RNA analysis
      • Exosomes Market Outlook
Revenue, 2025 (US$M)
$7.6
Estimate, 2026 (US$M)
$11.5
Forecast, 2033 (US$M)
$34.1
CAGR, 2026 - 2033
28.9%

Ask Prism AI anything about the exosomes market

Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.

Every answer starts with GVR research, and every figure is cited.Explore Prism AI

Japan exosomes market highlights

  • The Japan exosomes market generated a revenue of USD 7.6 million in 2024 and is expected to reach USD 34.1 million by 2030.
  • The Japan market is expected to grow at a CAGR of 28.9% from 2025 to 2030.
  • In terms of segment, kits & reagents was the largest revenue generating product in 2024.
  • Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.

Exosomes market data book summary

Market revenue in 2024USD 7.6 million
Market revenue in 2030USD 34.1 million
Growth rate28.9% (CAGR from 2025 to 2030)
Largest segmentKits & reagents
Fastest growing segmentKits & Reagents
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationKits & Reagents, Instruments, Services
Key market players worldwideDanaher Corp, Hologic Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, Miltenyi Biotec, Bio-Techne Corp, Qiagen NV, Thermo Fisher Scientific Inc, Abcam PLC, RoosterBio

Other key industry trends

  • In terms of revenue, Japan accounted for 4.3% of the global exosomes market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan exosomes market is projected to lead the regional market in terms of revenue in 2030.
  • Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 34.1 million by 2030.

Companies in this country are involved in collaborative efforts to develop novel tests and instruments. The government is encouraging the development of novel advancements in the market, which enable the efficient capture and quantitative analysis of exosomes.

These instruments are expected to support the early detection of cost-burden diseases such as cancer using blood samples. Furthermore, the country’s flexible regulatory environment attracts a significant number of foreign investments.

For instance, in April 2017, Biocept, Inc. was granted a patent for its “Devices & Methods for Cell Capture and Analysis.” Several overseas players are planning to invest in Japan to gain patent rights owing to the country’s regulatory and foreign investment policies.

No credit card required*

Publish Date: May 05, 2026

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study
Turnaround
5–10 working days

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Exosomes Market Companies

NameProfile# EmployeesHQWebsite
Lonza Group LtdView profile 18,000Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002www.lonza.com
FUJIFILM Holdings CorpView profile 83,7847-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052www.fujifilmholdings.com
Thermo Fisher Scientific IncView profile 122,000168 Third Avenue, Waltham, MA, United States, 02451www.thermofisher.com
Danaher CorpView profile 63,0002200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701www.danaher.com
Qiagen NVView profile 5,900Hulsterweg 82, Venlo, LI, Netherlands, 5912 PLwww.qiagen.com
Hologic IncView profile 6,990250 Campus Drive, Marlborough, MA, United States, 01752www.hologic.com
Bio-Techne CorpView profile 3,050614 McKinley Place N.E., Minneapolis, MN, United States, 55413www.bio-techne.com
Abcam PLCView profile 1,760Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AXwww.abcam.com
Miltenyi BiotecView profile 1001-5000Bergisch Gladbach, Nordrhein-Westfalen, Germany, Europewww.miltenyibiotec.com
RoosterBioView profile 1-10Frederick, Maryland, United States, North Americaroosterbio.com

Japan Exosomes Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Exosomes Market Outlook will help companies and investors design strategic landscapes.


Kits & Reagents was the largest segment with a revenue share of 57.89% in 2024.

Horizon Databook has segmented the Japan exosomes market based on kits & reagents, instruments, services covering the revenue growth of each sub-segment from 2018 to 2030.




Companies in this country are involved in collaborative efforts to develop novel tests and instruments. The government is encouraging the development of novel advancements in the market, which enable the efficient capture and quantitative analysis of exosomes.

These instruments are expected to support the early detection of cost-burden diseases such as cancer using blood samples. Furthermore, the country’s flexible regulatory environment attracts a significant number of foreign investments.

For instance, in April 2017, Biocept, Inc. was granted a patent for its “Devices & Methods for Cell Capture and Analysis.” Several overseas players are planning to invest in Japan to gain patent rights owing to the country’s regulatory and foreign investment policies.

  • Japan Exosomes Market Workflow Outlook (Revenue, USD Million , 2021-2033)
    • Isolation Methods
    • Downstream Analysis
  • Japan Exosomes Market Product Outlook (Revenue, USD Million , 2021-2033)
    • Kits & Reagents
    • Instruments
    • Services
  • Japan Exosomes Market End Use Outlook (Revenue, USD Million , 2021-2033)
    • Hospitals & diagnostics centers
    • Pharmaceutical & biotechnology companies
    • Academic & research institutes
  • Japan Exosomes Market Application Outlook (Revenue, USD Million , 2021-2033)
    • Neurodegenerative diseases
    • Cardiovascular diseases
    • Others
    • Cancer
    • Infectious diseases

Reasons to subscribe to Exosomes Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Exosomes Market Outlook databook

  • Our clientele includes a mix of Exosomes Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Japan Exosomes Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Japan Exosomes Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Japan Exosomes Market, 2021-2033 (US$M)

No Access Stack Chart

Japan exosomes market statistics, by workflow, 2021-2033 (US$M)

No Access Pie Chart

Japan exosomes market statistics, by workflow, 2021-2033 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more